The Gene Editing Service Market is expected to register a CAGR of 10.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Gene Editing Service Market report covers analysis by Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Other Technologies); Application (Cell Line Editing, Animal Genome Editing, Plant Genome Editing, Others); End-User (Pharmaceutical Companies And Biotechnology Companies, Academics And Government Research Institutes, Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Gene Editing Service Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Gene Editing Service Market Segmentation
Technology- Clustered Regularly Interspaced Short Palindromic Repeats
- Transcription Activator-Like Effector Nuclease
- Zinc Finger Nuclease
- Cell Line Editing
- Animal Genome Editing
- Plant Genome Editing
- Pharmaceutical Companies And Biotechnology Companies
- Academics And Government Research Institutes
- Clinical Research Organizations
Strategic Insights
Gene Editing Service Market Growth Drivers- Advances in CRISPR Technology: The introduction of CRISPR-Cas9 has revolutionized gene editing due to its simplicity, precision, and cost-effectiveness. This technology allows for more efficient gene modifications compared to older methods such as TALENs and ZFNs. CRISPR technology has gained widespread acceptance in research and therapy, driving demand for gene editing services. The continuous advancements and refinements in CRISPR technology, including CRISPR-based gene therapies, are fueling growth in the gene editing service market.
- Increasing Demand for Precision Medicine: As health care moves towards precision medicine, there is an increasing need for gene editing to provide tailored treatments. Gene editing technologies are part of the therapies tailored to an individual's genetic makeup, especially in the treatment of genetic disorders like sickle cell anemia, cystic fibrosis, and Duchenne muscular dystrophy. This is what has increased the demand for gene editing services in clinical applications, including gene therapy and cell-based therapies.
- Investments in Genetic Research and Biotechnology: Strong investment in genetic research and biotechnology is driving gene editing technologies and services. Today, research organizations, biotechnology companies, and pharmaceutical companies are also investing more in the exploration of gene editing prospects in gene therapy, oncology, and other inherited diseases. In June 2024, GenKOre from South Korea collaborated with Revvity from the United States to work on gene therapies for ocular disorders. GenKOre's TaRGET platform would be coupled with the vectors developed by Revvity to pursue in vivo gene editing for Leber Congenital Amaurosis 10 and Usher Syndrome Type 2A. The growth in private and public funding for genetic research is fostering the growth of the gene editing service market.
- Integration of gene editing with stem cell therapy: One of the most significant trends in the gene editing service market is the integration of gene editing techniques with stem cell therapy. Gene editing can be used to modify stem cells before they are used in therapies for treating genetic diseases, cancer, and autoimmune disorders. Combining gene editing with stem cell-based treatments offers the potential for more effective, personalized treatments for a wide range of conditions, including genetic mutations and tissue regeneration.
- Expansion in Agricultural Biotechnology: It plays a more dominant role in agricultural biotechnology today as it develops gene editing in application areas including improvement of crops, and pest and disease resistance. More and more genetically modified crops and livestock will come into use using gene editing services to further develop food security and nutritional enhancement besides reducing impacts on the environment. The urgent interest in developing a sustainable system for farming in this world demands a climate-resistance crop as one of the results of applying gene editing in this industry.
- Use of Gene Editing in Disease Modeling: The demand for gene editing services to develop disease models in research applications is increasing. Researchers can achieve more precise models of human diseases by adding a specific genetic mutation to a laboratory animal. These models are crucial for drug development, toxicology testing, and disease mechanism studies. In May 2024, Merck KGaA (Germany) acquired Mirus Bio, Inc. (US), integrating Mirus Bio's transfection technology with Merck's bioprocessing expertise. This acquisition, completed enhanced Merck's capabilities in viral vector manufacturing, advancing support for cell and gene therapies. Thus, the rising demand for gene-edited models in pharmaceutical and biotechnological drug discovery and preclinical research is creating demand for gene-editing services.
- Development of New Genomic Editing Instruments: Such developments will continue offering opportunities for building next-generation tools for genetic editing that are of higher precision and efficiency and can be safer for use. This will give such companies an upper hand in their endeavors when it comes to market competition. Agilent Technologies, Inc. in the United States acquired BIOVECTRA, Inc. (Canada) in July 2024. Its biopharma solutions were extended by the strength of BIOVECTRA's expertise in biologics and gene editing. Thus, Agilent's drug development and manufacturing capabilities would be expanded. Innovations in gene-editing tools are likely to break new grounds regarding safer and more efficient gene modifications; this will usher in new uses and further contribute to the expanding gene editing services market.
- Strategic Partnerships and Collaborations: Collaboration between biotech firms, pharmaceutical companies, academic institutions, and research organizations presents a significant opportunity for expanding gene editing services. By partnering with leaders in drug development and clinical research, gene editing service providers can expand their reach, access new technologies, and participate in large-scale clinical trials. In March 2023, GenScript (US) announced a strategic collaboration with PersonGen-Anke Cellular Therapeutics (US) to advance cell isolation products. The collaboration aimed to enhance the efficiency of developing and producing cell therapy. GenScript's CytoSinct platform was expected to support PersonGen in reducing costs and improving R&D efficiency in cell therapy. Strategic partnerships can accelerate the development of new therapies and increase the market visibility of gene editing services.
- Gene Editing for Agriculture and Food Security: The demand for sustainable food production methods is creating a strong opportunity for gene editing services in the agricultural sector. Gene editing can revolutionize food production systems by improving crop yields, resistance to pests, and environmental stress tolerance. Agricultural gene editing services that focus on genetically modified crops or livestock to meet the growing global demand for food are likely to experience significant market growth, particularly in regions facing food security challenges.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Gene Editing Service Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Gene Editing Service Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Gene Editing Service Market are Advances in CRISPR Technology, Increasing Demand for Precision Medicine, and Investments in Genetic Research and Biotechnology.
The key future trends of the market are Integration of gene editing with stem cell therapy, Expansion in Agricultural Biotechnology, and Use of Gene Editing in Disease Modeling.
The leading players operating in the Gene Editing Service Market include GenScript USA Inc., Horizon Discovery Group plc, Integrated DNA Technologies Inc., Lonza Group Ltd, Merck & Co., New England Biolabs Inc., Origene Technologies Inc., Sangamo Biosciences Inc., and Thermo Fisher Scientific Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gene Editing Service Market - By Technology
1.3.2 Gene Editing Service Market - By Application
1.3.3 Gene Editing Service Market - By End-User
1.3.4 Gene Editing Service Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENE EDITING SERVICE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENE EDITING SERVICE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GENE EDITING SERVICE MARKET - GLOBAL MARKET ANALYSIS
6.1. GENE EDITING SERVICE - GLOBAL MARKET OVERVIEW
6.2. GENE EDITING SERVICE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GENE EDITING SERVICE MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR)
7.3.1. Overview
7.3.2. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Forecast and Analysis
7.4. TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE (TALEN)
7.4.1. Overview
7.4.2. Transcription Activator-Like Effector Nuclease (TALEN) Market Forecast and Analysis
7.5. ZINC FINGER NUCLEASE (ZFN)
7.5.1. Overview
7.5.2. Zinc Finger Nuclease (ZFN) Market Forecast and Analysis
7.6. OTHER TECHNOLOGIES
7.6.1. Overview
7.6.2. Other Technologies Market Forecast and Analysis
8. GENE EDITING SERVICE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CELL LINE EDITING
8.3.1. Overview
8.3.2. Cell Line Editing Market Forecast and Analysis
8.4. ANIMAL GENOME EDITING
8.4.1. Overview
8.4.2. Animal Genome Editing Market Forecast and Analysis
8.5. PLANT GENOME EDITING
8.5.1. Overview
8.5.2. Plant Genome Editing Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. GENE EDITING SERVICE MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL COMPANIES AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical Companies And Biotechnology Companies Market Forecast and Analysis
9.4. ACADEMICS AND GOVERNMENT RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academics And Government Research Institutes Market Forecast and Analysis
9.5. CLINICAL RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Clinical Research Organizations Market Forecast and Analysis
10. GENE EDITING SERVICE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Gene Editing Service Market Overview
10.1.2 North America Gene Editing Service Market Forecasts and Analysis
10.1.3 North America Gene Editing Service Market Forecasts and Analysis - By Technology
10.1.4 North America Gene Editing Service Market Forecasts and Analysis - By Application
10.1.5 North America Gene Editing Service Market Forecasts and Analysis - By End-User
10.1.6 North America Gene Editing Service Market Forecasts and Analysis - By Countries
10.1.6.1 United States Gene Editing Service Market
10.1.6.1.1 United States Gene Editing Service Market by Technology
10.1.6.1.2 United States Gene Editing Service Market by Application
10.1.6.1.3 United States Gene Editing Service Market by End-User
10.1.6.2 Canada Gene Editing Service Market
10.1.6.2.1 Canada Gene Editing Service Market by Technology
10.1.6.2.2 Canada Gene Editing Service Market by Application
10.1.6.2.3 Canada Gene Editing Service Market by End-User
10.1.6.3 Mexico Gene Editing Service Market
10.1.6.3.1 Mexico Gene Editing Service Market by Technology
10.1.6.3.2 Mexico Gene Editing Service Market by Application
10.1.6.3.3 Mexico Gene Editing Service Market by End-User
10.2. EUROPE
10.2.1 Europe Gene Editing Service Market Overview
10.2.2 Europe Gene Editing Service Market Forecasts and Analysis
10.2.3 Europe Gene Editing Service Market Forecasts and Analysis - By Technology
10.2.4 Europe Gene Editing Service Market Forecasts and Analysis - By Application
10.2.5 Europe Gene Editing Service Market Forecasts and Analysis - By End-User
10.2.6 Europe Gene Editing Service Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Gene Editing Service Market
10.2.6.1.1 Germany Gene Editing Service Market by Technology
10.2.6.1.2 Germany Gene Editing Service Market by Application
10.2.6.1.3 Germany Gene Editing Service Market by End-User
10.2.6.2 France Gene Editing Service Market
10.2.6.2.1 France Gene Editing Service Market by Technology
10.2.6.2.2 France Gene Editing Service Market by Application
10.2.6.2.3 France Gene Editing Service Market by End-User
10.2.6.3 Italy Gene Editing Service Market
10.2.6.3.1 Italy Gene Editing Service Market by Technology
10.2.6.3.2 Italy Gene Editing Service Market by Application
10.2.6.3.3 Italy Gene Editing Service Market by End-User
10.2.6.4 Spain Gene Editing Service Market
10.2.6.4.1 Spain Gene Editing Service Market by Technology
10.2.6.4.2 Spain Gene Editing Service Market by Application
10.2.6.4.3 Spain Gene Editing Service Market by End-User
10.2.6.5 United Kingdom Gene Editing Service Market
10.2.6.5.1 United Kingdom Gene Editing Service Market by Technology
10.2.6.5.2 United Kingdom Gene Editing Service Market by Application
10.2.6.5.3 United Kingdom Gene Editing Service Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Gene Editing Service Market Overview
10.3.2 Asia-Pacific Gene Editing Service Market Forecasts and Analysis
10.3.3 Asia-Pacific Gene Editing Service Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Gene Editing Service Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Gene Editing Service Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Gene Editing Service Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Gene Editing Service Market
10.3.6.1.1 Australia Gene Editing Service Market by Technology
10.3.6.1.2 Australia Gene Editing Service Market by Application
10.3.6.1.3 Australia Gene Editing Service Market by End-User
10.3.6.2 China Gene Editing Service Market
10.3.6.2.1 China Gene Editing Service Market by Technology
10.3.6.2.2 China Gene Editing Service Market by Application
10.3.6.2.3 China Gene Editing Service Market by End-User
10.3.6.3 India Gene Editing Service Market
10.3.6.3.1 India Gene Editing Service Market by Technology
10.3.6.3.2 India Gene Editing Service Market by Application
10.3.6.3.3 India Gene Editing Service Market by End-User
10.3.6.4 Japan Gene Editing Service Market
10.3.6.4.1 Japan Gene Editing Service Market by Technology
10.3.6.4.2 Japan Gene Editing Service Market by Application
10.3.6.4.3 Japan Gene Editing Service Market by End-User
10.3.6.5 South Korea Gene Editing Service Market
10.3.6.5.1 South Korea Gene Editing Service Market by Technology
10.3.6.5.2 South Korea Gene Editing Service Market by Application
10.3.6.5.3 South Korea Gene Editing Service Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Gene Editing Service Market Overview
10.4.2 Middle East and Africa Gene Editing Service Market Forecasts and Analysis
10.4.3 Middle East and Africa Gene Editing Service Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Gene Editing Service Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Gene Editing Service Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Gene Editing Service Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Gene Editing Service Market
10.4.6.1.1 South Africa Gene Editing Service Market by Technology
10.4.6.1.2 South Africa Gene Editing Service Market by Application
10.4.6.1.3 South Africa Gene Editing Service Market by End-User
10.4.6.2 Saudi Arabia Gene Editing Service Market
10.4.6.2.1 Saudi Arabia Gene Editing Service Market by Technology
10.4.6.2.2 Saudi Arabia Gene Editing Service Market by Application
10.4.6.2.3 Saudi Arabia Gene Editing Service Market by End-User
10.4.6.3 U.A.E Gene Editing Service Market
10.4.6.3.1 U.A.E Gene Editing Service Market by Technology
10.4.6.3.2 U.A.E Gene Editing Service Market by Application
10.4.6.3.3 U.A.E Gene Editing Service Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Gene Editing Service Market Overview
10.5.2 South and Central America Gene Editing Service Market Forecasts and Analysis
10.5.3 South and Central America Gene Editing Service Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Gene Editing Service Market Forecasts and Analysis - By Application
10.5.5 South and Central America Gene Editing Service Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Gene Editing Service Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Gene Editing Service Market
10.5.6.1.1 Brazil Gene Editing Service Market by Technology
10.5.6.1.2 Brazil Gene Editing Service Market by Application
10.5.6.1.3 Brazil Gene Editing Service Market by End-User
10.5.6.2 Argentina Gene Editing Service Market
10.5.6.2.1 Argentina Gene Editing Service Market by Technology
10.5.6.2.2 Argentina Gene Editing Service Market by Application
10.5.6.2.3 Argentina Gene Editing Service Market by End-User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENE EDITING SERVICE MARKET, KEY COMPANY PROFILES
12.1. GENSCRIPT USA INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HORIZON DISCOVERY GROUP PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. INTEGRATED DNA TECHNOLOGIES INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. LONZA GROUP LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NEW ENGLAND BIOLABS INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ORIGENE TECHNOLOGIES INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANGAMO BIOSCIENCES INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. THERMO FISHER SCIENTIFIC INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TRANSPOSAGEN BIOPHARMACEUTICALS INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. GenScript USA Inc.
2. Horizon Discovery Group plc
3. Integrated DNA Technologies Inc.
4. Lonza Group Ltd
5. Merck & Co.
6. New England Biolabs Inc.
7. Origene Technologies Inc.
8. Sangamo Biosciences Inc.
9. Thermo Fisher Scientific Inc.
10. Transposagen Biopharmaceuticals Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For